Search results :

PEP005

More information: STITCH, PubChem and possibly Wikipedia

ATC Codes: None found

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3
Erythema 0% - 94.2% x x x
Application site erythema very common x x
Application site vesicles very common x x
Application site pustules very common x x
Application site scab very common x x
Application site swelling very common x x
Application site exfoliation very common x x
Application site erosion very common x x
Scab 0% - 80.3% x x x
Application site pruritus common, 0% - 8.03% x x x
Swelling 0% - 79.2% x x x
Periorbital oedema common, 0% - 2.55% x x x
Application site infection common, 0% - 2.55% x x x
Headache common, 1.11% - 2.19% x x x
Application site irritation common, 0.431% - 3.56% x x x
Eyelid oedema uncommon, common x x x
Application site pain common, 0% - 15.3% x x x
Nasopharyngitis 0.862% - 1.78% x
Ulcer 0% - 31.8% x x x
Eye pain uncommon x x
Application site ulcer uncommon x x
Application site warmth uncommon x
Application site paraesthesia uncommon x x
Application site discharge uncommon x
Infection x x
Conjunctivitis x
Eye disorder x x
Nervous system disorder x x
Infestation NOS x x
Application site burn x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

ingenol mebutate

Side effects:14
Source:FDA Structured Product Label

Ingenol mebutate 0.015% / Picato, Topical gel

Side effects:24
Source:Medsafe

ingenol mebutate / ingenol mebutate

Side effects:28
Source:EMA

Color scheme:

standardalternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label